首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
【24h】

Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides

机译:硫酸化壳寡糖改善aFGF对周围神经损伤修复的保护作用

获取原文
       

摘要

Injury to the peripheral nerves can result in temporary or life-long neuronal dysfunction and subsequent economic or social disability. Acidic fibroblast growth factor (aFGF) promotes the growth and survival of neurons and is a possible treatment for peripheral nerve injury. Yet, the actual therapeutic utility of aFGF is limited by its short half-life and instability in vivo . In the present study, we prepared sulfated chitooligosaccharides (SCOS), which have heparin-like properties, to improve the bioactivity of aFGF. We investigated the protective effects of SCOS with or without aFGF on RSC96 cells exposed to Nasub2/subSsub2/subOsub4/sub hypoxia/reoxygenation injury. Cell viability was measured by MTT assay and cytotoxicity induced by Nasub2/subSsub2/subOsub4/sub was assessed by lactate dehydrogenase (LDH) release into the culture medium. Pretreatment with aFGF and SCOS dramatically decreased LDH release after injury compared to pretreatment with aFGF or SCOS alone. We subsequently prepared an aFGF/SCOS thermo-sensitive hydrogel with poloxamer and examined its effects in vivo . Paw withdrawal thresholds and thermal withdrawal latencies were measured in rats with sciatic nerve injury. Local injection of the aFGF/SCOS hydrogels (aFGF: 40, 80?μg/kg) increased the efficiency of sciatic nerve repair compared to aFGF (80?μg/kg) hydrogel alone. Especially aFGF/SCOS thermo-sensitive hydrogel decreased paw withdrawal thresholds from 117.75?±?8.38 (g, 4 d) to 65.74?±?3.39 (g, 10 d), but aFGF alone group were 140.58?±?27.54 (g, 4 d) to 89.12?±?5.60 (g, 10 d) (aFGF dose was 80?μg/kg, P ?0.05, n ?=?8). The thermal withdrawal latencies decreased from 11.61?±?2.26 (s, 4 d) to 2.37?±0.67 (s, 10 d). However, aFGF alone group were from 17.69?±?1.47 (s, 4 d) to 4.65?±?1.73 (s, 10 d) ( P ?0.05, n ?=?8). Furthermore, the aFGF/SCOS hydrogels also exhibited good biocompatibility in mice. In summary, SCOS improved the protective effects of aFGF in RSC96 cells injured with Nasub2/subSsub2/subOsub4/sub and increased the efficiency of nerve repair and recovery of function in rats with sciatic nerve injury. These findings pave an avenue for the development of novel prophylactic and therapeutic strategies for peripheral nerve injury.
机译:周围神经损伤可导致暂时或终生神经元功能障碍,并随后导致经济或社会残疾。酸性成纤维细胞生长因子(aFGF)促进神经元的生长和存活,是治疗周围神经损伤的一种可能方法。然而,aFGF的实际治疗用途受到其短的半衰期和体内不稳定性的限制。在本研究中,我们制备了具有类似肝素特性的硫酸化壳寡糖(SCOS),以提高aFGF的生物活性。我们研究了有或没有aFGF的SCOS对暴露于Na 2 S 2 O 4 缺氧/复氧损伤的RSC96细胞的保护作用。通过MTT法测定细胞活力,并通过乳酸脱氢酶(LDH)释放到培养物中来评估Na 2 S 2 O 4 诱导的细胞毒性中。与单独使用aFGF或SCOS进行预处理相比,使用aFGF和SCOS进行预处理可显着降低受伤后LDH的释放。我们随后制备了具有泊洛沙姆的aFGF / SCOS热敏水凝胶,并检查了其在体内的作用。在坐骨神经损伤的大鼠中测量爪撤出阈值和热撤出潜伏期。与单独使用aFGF(80?μg/ kg)水凝胶相比,局部注射aFGF / SCOS水凝胶(aFGF:40,80?μg/ kg)可以提高坐骨神经修复的效率。尤其是aFGF / SCOS热敏水凝胶将爪子撤离阈值从117.75?±?8.38(g,4 d)降低至65.74?±?3.39(g,10 d),但仅aFGF组为140.58?±?27.54 4d)至89.12≤±5.60(g,10d)(aFGF剂量为80μg/ kg,P <≤0.05,n≤= 8)。散热延迟从11.61±±2.26(s,4 d)降低到2.37±0.67(s,10 d)。但是,单独的aFGF组为17.69±±1.47(s,4d)至4.65±±1.73(s,10d)(P <α0.05,n≥3)。此外,aFGF / SCOS水凝胶在小鼠中也表现出良好的生物相容性。总之,SCOS改善了aFGF对Na 2 S 2 O 4 损伤的RSC96细胞的保护作用,并提高了神经修复和修复的效率。坐骨神经损伤大鼠的功能恢复这些发现为周围神经损伤的新型预防和治疗策略的发展铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号